In addition, BCL6 maintains Foxp3 expression and promotes the suppressive ability of tumor-infiltrating Treg cells, and thus high BCL6 levels in Treg cells represent a poor prognosis marker in patients with colorectal cancer & melanoma (128). This evidence concerns the gene BCL6 and neoplasm.